Subcutaneous Adipose Tissue Transcriptome Highlights Specific Expression Profiles in Severe Pediatric Obesity: A Pilot Study.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Pediatric Obesity*/genetics ; Obesity, Morbid*; Humans ; Male ; Child ; Overweight/genetics ; Pilot Projects ; Transcriptome/genetics ; Subcutaneous Fat

The prevalence of pediatric obesity is rising rapidly worldwide, and "omic" approaches are helpful in investigating the molecular pathophysiology of obesity. This work aims to identify transcriptional differences in the subcutaneous adipose tissue (scAT) of children with overweight (OW), obesity (OB), or severe obesity (SV) compared with those of normal weight (NW). Periumbilical scAT biopsies were collected from 20 male children aged 1-12 years. The children were stratified into the following four groups according to their BMI z-scores: SV, OB, OW, and NW. scAT RNA-Seq analyses were performed, and a differential expression analysis was conducted using the DESeq2 R package. A pathways analysis was performed to gain biological insights into gene expression. Our data highlight the significant deregulation in both coding and non-coding transcripts in the SV group when compared with the NW, OW, and OB groups. A KEGG pathway analysis showed that coding transcripts were mainly involved in lipid metabolism. A GSEA analysis revealed the upregulation of lipid degradation and metabolism in SV vs. OB and SV vs. OW. Bioenergetic processes and the catabolism of branched-chain amino acids were upregulated in SV compared with OB, OW, and NW. In conclusion, we report for the first time that a significant transcriptional deregulation occurs in the periumbilical scAT of children with severe obesity compared with those of normal weight or those with overweight or mild obesity.

Curr Opin Endocrinol Diabetes Obes. 2009 Feb;16(1):10-5. (PMID: 19115520)
Metabolites. 2021 Dec 30;12(1):. (PMID: 35050149)
Int J Mol Sci. 2021 Feb 17;22(4):. (PMID: 33671464)
Trends Microbiol. 2019 Dec;27(12):997-1010. (PMID: 31474424)
Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2329-2334. (PMID: 31405638)
J Clin Endocrinol Metab. 2010 Dec;95(12):5419-26. (PMID: 20843952)
Front Endocrinol (Lausanne). 2021 Mar 12;12:599134. (PMID: 33776911)
Diabetologia. 1985 Jul;28(7):412-9. (PMID: 3899825)
Biomedicines. 2022 Aug 11;10(8):. (PMID: 36009499)
Data Brief. 2021 Nov 27;39:107647. (PMID: 34901353)
Nat Commun. 2022 Oct 13;13(1):6030. (PMID: 36229481)
Indian J Med Res. 2019 May;149(5):571-573. (PMID: 31417024)
Nat Chem Biol. 2016 Jan;12(1):15-21. (PMID: 26571352)
Front Physiol. 2020 Jan 29;10:1607. (PMID: 32063863)
Physiol Genomics. 2016 Dec 1;48(12):897-911. (PMID: 27764764)
Eur Neuropsychopharmacol. 2015 Jan;25(1):1-16. (PMID: 25523882)
Front Physiol. 2021 Jun 30;12:689747. (PMID: 34276410)
PLoS One. 2016 Sep 14;11(9):e0162167. (PMID: 27627109)
J Obes Metab Syndr. 2021 Jun 30;30(2):115-123. (PMID: 33820878)
Rev Med Suisse. 2008 Apr 2;4(151):844-7. (PMID: 18488747)
Arch Dis Child. 1969 Jun;44(235):291-303. (PMID: 5785179)
Metab Syndr Relat Disord. 2008 Dec;6(4):299-304. (PMID: 19067533)
Front Physiol. 2020 Jan 22;10:1638. (PMID: 32038305)
Front Neurosci. 2018 Nov 01;12:813. (PMID: 30443205)
Nat Metab. 2022 Jan;4(1):106-122. (PMID: 35075301)
Sci Rep. 2021 Sep 15;11(1):18329. (PMID: 34526523)
Cardiovasc Diabetol. 2020 Jun 13;19(1):79. (PMID: 32534575)
Sci Rep. 2018 Jun 8;8(1):8750. (PMID: 29884798)
Int J Oral Maxillofac Surg. 1986 Feb;15(1):25-9. (PMID: 3083002)
Nat Biotechnol. 2014 Sep;32(9):926-32. (PMID: 25150839)
Clin Transl Med. 2022 Jan;12(1):e706. (PMID: 35040588)
Mol Aspects Med. 2013 Feb;34(1):1-11. (PMID: 23068073)
Obes Rev. 2010 Jan;11(1):11-8. (PMID: 19656312)
Front Pediatr. 2020 Oct 09;8:551103. (PMID: 33163464)
PLoS One. 2015 Jun 05;10(6):e0127389. (PMID: 26047327)
Genomics. 2021 Nov;113(6):3919-3934. (PMID: 34555498)
Sci Rep. 2022 Nov 29;12(1):20313. (PMID: 36446824)
J Clin Res Pediatr Endocrinol. 2019 May 15;:. (PMID: 31088046)
Am J Clin Nutr. 2017 Sep;106(3):736-746. (PMID: 28793995)
Cells. 2021 Jun 23;10(7):. (PMID: 34201844)
Bull World Health Organ. 2007 Sep;85(9):660-7. (PMID: 18026621)
Diabetes Metab Syndr Obes. 2020 May 11;13:1575-1585. (PMID: 32494174)
Health Qual Life Outcomes. 2020 Apr 6;18(1):93. (PMID: 32252769)
Curr Opin Lipidol. 2016 Jun;27(3):288-94. (PMID: 27031277)
Ann Pediatr Endocrinol Metab. 2019 Sep;24(3):172-179. (PMID: 31607110)
J Nutr Biochem. 2016 Apr;30:126-32. (PMID: 27012629)
Nutrients. 2020 Sep 08;12(9):. (PMID: 32911676)
Curr Opin Lipidol. 2005 Oct;16(5):549-53. (PMID: 16148540)
Metabolism. 2019 Mar;92:163-169. (PMID: 30385379)
Endocr Res. 2020 Nov;45(4):233-240. (PMID: 32791927)
Genes (Basel). 2022 Oct 15;13(10):. (PMID: 36292751)
Trends Endocrinol Metab. 2021 Oct;32(10):747-749. (PMID: 34158225)
Front Physiol. 2022 Feb 24;13:826314. (PMID: 35283787)

Keywords: RNA-Seq; childhood obesity; lipid metabolism; long non-coding RNAs; overweight; periumbilical subcutaneous adipose tissue

Date Created: 20230516 Date Completed: 20230517 Latest Revision: 20230519

20230519

PMC10137076

10.3390/cells12081105

37190014